Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Study Phase : Discovery
Sponsor : biotx.ai
Deal Size : Undisclosed
Deal Type : Partnership
3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling
Details : The partnership aims at revolutionizing ADHD drug development by leveraging advanced AI modelling techniques to bridge the gap between animal studies and human clinical trials, enabling a more efficient and accurate translation of promising therapeutics.
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
August 18, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Discovery
Sponsor : biotx.ai
Deal Size : Undisclosed
Deal Type : Partnership
LOOKING FOR A SUPPLIER?